Chang Hyung Lee

Dr. Chang Hyung Lee

School of Pharmacy, Sungkyunkwan, Suwon, Gyeonggi, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
MKMin-Hwan Kim
Min-Hwan Kim
KKKi-Taek Kim
Ki-Taek Kim
SSSeo-Yeon Sohn
Seo-Yeon Sohn
JLJae-Young Lee
Jae-Young Lee
Chang Hyung LeeChang Hyung Lee
Chang Hyung Lee
DKDae-Duk Kim
Dae-Duk Kim
Background: 20(S)-Protopanaxadiol (PPD) has a higher anti-wrinkle effect than the other glycone forms of ginsenosides. However, as PPD has low solubility in water and a high molecular weight, it cannot easily penetrate the stratum corneum layer, which is the rate-limiting step of topical skin delivery. Thus, the objective was to enhance the topical skin deposition of PPD using an optimized nanostructured lipid carriers (NLC) formulation. NLC formulations were optimized using a Box-Behnken design. Materials and methods: NLC formulations were optimized using a Box-Behnken design, where the amount of PDD (X1), volume of the liquid lipid (X2), and amount of surfactant (X3) were set as the independent variables, while the particle size (Y1), polydispersity index (PDI) (Y2), and entrapment efficiency (EE) (Y3) were dependent factors. An in vitro deposition study was performed using Strat-M® and human cadaver skin, while in vivo skin irritation effect of the NLC formulation was evaluated in humans. Results: An NLC was successfully prepared based on the optimized formulation determined using the Box-Behnken design. The particle size, PDI, and EE of the NLC showed less than 5% difference from the predicted values. The in vitro deposition of PPD after the application of the NLC formulation on a Strat-M® artificial membrane and human cadaver skin was significantly higher than that of the controls. Moreover, NLC formulations with and without PDD were not skin irritants in a human study. Conclusion: An NLC formulation for the topical delivery of PPD was successfully optimized using the Box-Behnken design, and could be further developed to enhance the topical skin deposition of PPD.

5 December 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
HSHyeong-U Son
Hyeong-U Son
EYEun-Kyeong Yoon
Eun-Kyeong Yoon
CYChi-Yeol Yoo
Chi-Yeol Yoo
CPChul-Hong Park
Chul-Hong Park
MBMyung Ae Bae
Myung Ae Bae
Sang-Han LeeSang-Han Lee
Sang-Han Lee
To determine the mechanism of action of the effects of phytoalexins in soybeans, we analyzed α-glucosidase inhibition kinetics using Michaelis–Menten plots and Lineweaver–Burk plots. The results showed that the type of inhibition with glyceollin was competitive, that of genistein was noncompetitive, that of daidzein was uncompetitive, and luteolin showed a mixed mode of action. The Ki values were determined using a Dixon plot as glyceollin, 18.99 μM; genistein, 15.42 μM; luteolin, 16.81 μM; and daidzein, 9.99 μM. Furthermore, potential synergistic effects between glyceollin and the three polyphenols were investigated. A combination of glyceollin and luteolin at a ratio of 3:7 exhibited synergistic effects on α-glucosidase inhibition, having a combination index (CI) of 0.64244, according to the CI–isobologram equation. Collectively, these results showed that a combination of glyceollin and luteolin has the potential to inhibit α-glucosidase activity via a synergistic mode of inhibition.

12 June 2024 in Phytomedicine
Verified
Journal Article
Closed access
CKChang-Woo Kim
Chang-Woo Kim
MAMD BADRUL ALAM
MD BADRUL ALAM
BSBo-Rim Song
Bo-Rim Song
Chang Hyung LeeChang Hyung Lee
Chang Hyung Lee
SKSolomon L. Kim
Solomon L. Kim
Sang-Han LeeSang-Han Lee
Sang-Han Lee

4 June 2019 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
Jong-Eun KimJong-Eun Kim
Jong-Eun Kim
SJSeul‐Gi Jang
Seul‐Gi Jang
Chang Hyung LeeChang Hyung Lee
Chang Hyung Lee
JLJi Yun Lee
Ji Yun Lee
Haenim ParkHaenim Park
Haenim Park
Han-Seung ShinHan-Seung Shin
Han-Seung Shin

Verified
Journal Article
Open access
PDF file
HKHeerim Kang
Heerim Kang
Chang Hyung LeeChang Hyung Lee
Chang Hyung Lee
JKJong Rhan Kim
Jong Rhan Kim
JKJung Yeon Kwon
Jung Yeon Kwon
SSSang Gwon Seo
Sang Gwon Seo
KLKi Won Lee
Ki Won Lee
Atopic dermatitis (AD) is a chronic and inflammatory skin disease that can place a significant burden on quality of life for patients. AD most frequently appears under the age of six and although its prevalence is increasing worldwide, therapeutic treatment options are limited. Chlorella vulgaris (CV) is a species of the freshwater green algae genus chlorella, and has been reported to modulate allergy-inducible factors when ingested. Here, we examined the effect of CV supplementation on AD-like symptoms in NC/Nga mice. CV was orally administrated for six weeks while AD-like symptoms were induced via topical application of Dermatophagoides farinae extract (DFE). CV treatment reduced dermatitis scores, epidermal thickness, and skin hydration. Histological analysis also revealed that CV treatment reduced DFE-induced eosinophil and mast cell infiltration into the skin, while analysis of serum chemokine levels indicated that CV treatment downregulated thymus- and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC) levels. In addition, CV treatment downregulated mRNA expression levels of IL-4 and IFN-γ. Taken together, these results suggest that CV extract may have potential as a nutraceutical ingredient for the prevention of AD.

27 September 2019 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PDF file
WKWoon-Ki Kim
Woon-Ki Kim
YJYou Jin Jang
You Jin Jang
DHDae Hee Han
Dae Hee Han
BSBoram Seo
Boram Seo
SPSungJun Park
SungJun Park
GKGwangPyo Ko
GwangPyo Ko
Gut microbiota play an important role in immune responses and energy metabolism. In this study, we evaluated whether administration of Lactobacillus fermentum (L. fermentum) KBL375 isolated from healthy Korean feces improves the atopic dermatitis using the house dust mite (Dermatophagoides farinae)-induced atopic dermatitis (AD) mouse model. Administration of L. fermentum KBL375 significantly decreased dermatitis score, ear and dorsal thickness, and serum immunoglobulin E level in AD-induced mice. Significant reductions in mast cells and eosinophils were discovered in skin tissues from L. fermentum KBL375-treated mice. T helper 2 cell-related cytokines interleukin (IL)-4, IL-5, IL-13, and IL-31 significantly decreased, and anti-inflammatory cytokine IL-10 or transforming growth factor-β increased in skin tissues from L. fermentum KBL375-treated mice. In addition to phenotypic changes in skin tissues, L. fermentum KBL375 treatment induced an increase in the CD4+CD25+Foxp3+ cell population in mesenteric lymph nodes. Taxonomic and functional analyses of gut microbiota showed significantly higher cecum bacterial diversities and abundances including genus Bilophila, Dorea, and Dehalobacterium in L. fermentum KBL375-treated mice. Metabolic analysis of the cecum also showed significant changes in the levels of various amino acids including methionine, phenylalanine, serine, and tyrosine, as well as short chain fatty acids such as acetate, butyrate, and propionate in AD-induced mice due to L. fermentum KBL375 treatment. These altered metabolites in AD-induced mice returned to the levels similar to those in control mice when treated with L. fermentum KBL375. Therefore, L. fermentum KBL375 could be useful for AD treatment by modulating the immune system and inducing various metabolites.